Navamedic ASA: Proposes IPO for Medtech division
Oslo, 14 May 2019 – The Board of Directors of Navamedic ASA (OSE: NAVA) has decided to propose for the Extraordinary General Assembly to separately list the Medtech division on the Oslo Stock Exchange in the third quarter of 2019. The division is commercialising Sippi®, a new proprietary system for digital, wireless, urine measurement in global markets, with a significant long-term revenue potential. “The Medtech division is commercialising Sippi, a new standard for urine monitoring which enables automated digital measurement, with a global market potential. This is the last manual and